Bringing breakthrough immunotherapies to patients with cancer

Vicus is employing immunotherapy to selectively target signaling pathways that lead to tumor-promoting inflammation, tumor immune escape and inflammation-potentiated toxicities. Our goal is to bring breakthrough immunotherapies to patients with cancer.